An electrochemically active creatinine binding device is provided to detect and measure quantitatively creatinine in biological samples. The device of the present invention is also provided with a device to detect and measure quantitatively creatinine and albumin bioanalytes simultaneously and to determine albumin to creatinine ratio (ACR). The present invention also provides an electrochemically active creatinine binding and albumin binding device for collection and retention of biological samples having creatinine and albumin bioanalytes. In the present invention a device holder is provided to receive the electrochemically active creatinine binding and albumin binding device. The device point of care biosensor and the method of the present invention facilitate quantitative measurement of creatinine and albumin bioanalytes in urine and blood samples and albumin to creatinine ratio (ACR) in urine samples electrochemically by determining redox current values. FIG.5a
